Document 0560
 DOCN  M9480560
 TI    Comparative contraceptive efficacy of the female condom and other
       barrier methods.
 DT    9410
 AU    Trussell J; Sturgen K; Strickler J; Dominik R; Woodrow Wilson School of
       Public and International Affairs,; Princeton University, N.J.
 SO    Fam Plann Perspect. 1994 Mar-Apr;26(2):66-72. Unique Identifier :
       AIDSLINE MED/94307358
 AB    Because the research design for the clinical trial establishing the
       contraceptive efficacy of the female condom--a six-month life-table
       probability of failure of 15% (12% in the United States vs. 22% in Latin
       America)--did not include randomization with another method of
       contraception, no definite conclusion about its comparative efficacy is
       possible. Comparisons using other female barrier methods as historical
       controls, however, provide evidence that, among women in the United
       States, the contraceptive efficacy of the female condom during typical
       use is not significantly different from that of the diaphragm, the
       sponge or the cervical cap. The six-month probability of failure during
       perfect use of the female condom is 2.6% among U.S. women, similar to
       rates for the diaphragm and the cervical cap but significantly lower
       than that for the sponge. Meaningful comparisons with the male condom
       are not possible because of the lack of data from carefully controlled
       prospective clinical trials. Extrapolations from the results on
       contraceptive efficacy suggest that perfect use of the female condom may
       reduce the annual risk of acquiring the human immunodeficiency virus by
       more than 90% among women who have intercourse twice weekly with an
       infected male.
 DE    Clinical Trials  Comparative Study  Condoms/*STANDARDS  Contraceptive
       Devices, Female/*STANDARDS  Female  Human  HIV
       Infections/EPIDEMIOLOGY/PREVENTION & CONTROL/TRANSMISSION  Latin America
       Life Tables  Male  Patient Compliance  Research Design  Risk Factors
       United States  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).